By A Mystery Man Writer
Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.
Novartis appoints Patrick Horber, M.D., President, International as Marie- France Tschudin, President, Innovative Medicines International and Chief Commercial Officer, steps down from the Executive Committee of Novartis
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
UPDATED: Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead - ECHEMI
organisation current research and strategies 2011 - 2012 - eortc
Novartis: Half of 1,400 Swiss Job Cuts are Leadership Positions
2024 SHORTLIST JURY - New York Festivals
Novartis is losing its chief commercial officer - STAT
Vas Narasimhan on LinkedIn: Of all the achievements Novartis shared yesterday to mark our Annual…
Novartis to lay off another 103 people at US HQ
Panelist Biography: Marie-France Paquet - Centre for European Studies